Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine.
Intermittent preventive treatment (IPT) is used to reduce malaria morbidity and mortality, especially in vulnerable groups such as children and pregnant women. IPT with the fixed dose combination of piperaquine (PQ) and dihydroartemisinin (DHA) is being evaluated as a potential mass treatment to con...
Những tác giả chính: | Permala, J, Tarning, J, Nosten, F, White, N, Karlsson, M, Bergstrand, M |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
American Society for Microbiology
2017
|
Những quyển sách tương tự
-
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
Bằng: Chotsiri, P, et al.
Được phát hành: (2019) -
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
Bằng: Palang Chotsiri, et al.
Được phát hành: (2019-01-01) -
Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.
Bằng: Bergstrand, M, et al.
Được phát hành: (2014) -
Efficacy and safety of dihydroartemisinin-piperaquine.
Bằng: Myint, H, et al.
Được phát hành: (2007) -
Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
Bằng: Lwin, K, et al.
Được phát hành: (2012)